| 【Fixed Income Research】DALWAN: Summary of our recent Q&As with clients |
| 【公司研究】迈瑞医疗 (300760 CH) – 业绩增长稳健，新兴市场引领海外发展 |
| 【Sector Research】China Consumer – Expecting encouraging data from the 5.1 holiday this year |
| 【Company Research】Zoomlion (000157 CH) – 1Q23 earnings slightly below expectation but recovery trend largely on track |
| 【Company Research】BYD Company (1211 HK) – 1Q23 earnings as a mixed bag |
| 【Company Research】Zoomlion (1157 HK) – 1Q23 earnings slightly below expectation but recovery trend largely on track |
| 【Company Research】AIA Group Ltd. (1299 HK) – Strong 1Q23 momentum |
| 【Company Research】Tigermed (300347 CH) – Healthy non-COVID revenue growth in 1Q23 |
| 【Company Research】Ping An (2318 HK) – VNB growth beat expectation in 1Q23; Profits and book value increased under IFRS 17 |
| 【Company Research】Vesync (2148 HK) – Signs of turnaround are forming in 1Q23 |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
